Antonio Tursi Selected Research

Diverticulum

1/2021	Therapeutic Response to Adalimumab in a Case of Steroid-Dependent Segmental Colitis Associated With Diverticulosis.
10/2016	Current Management of Patients With Diverticulosis and Diverticular Disease: A Survey From the 2nd International Symposium on Diverticular Disease.
3/2015	Moderate to severe and prolonged left lower-abdominal pain is the best symptom characterizing symptomatic uncomplicated diverticular disease of the colon: a comparison with fecal calprotectin in clinical setting.
8/2012	Onset of segmental colitis associated with diverticulosis after treatment with bevacizumab for metastatic colorectal carcinoma.
12/2011	Tumour necrosis factor-alpha expression in segmental colitis associated with diverticulosis down-regulates after treatment.
9/2008	Pattern of mucosal tumor necrosis factor-alpha expression in segmental colitis associated with diverticula suggests a truly autonomous clinical entity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Tursi Research Topics

Disease

31	Diverticular Diseases 01/2020 - 01/2004
30	Diverticulitis 06/2022 - 01/2004
22	Ulcerative Colitis 02/2022 - 11/2004
19	Crohn Disease (Crohn's Disease) 02/2022 - 01/2003
14	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2022 - 11/2011
9	Celiac Disease (Celiac Sprue) 08/2013 - 07/2002
7	Inflammation (Inflammations) 03/2021 - 01/2009
7	Infections 01/2020 - 07/2002
6	Colitis 10/2021 - 08/2005
6	Diverticulum 01/2021 - 09/2008
6	Abdominal Pain (Pain, Abdominal) 09/2018 - 03/2015
5	COVID-19 04/2022 - 01/2020
4	Necrosis 10/2020 - 12/2011
3	Pain (Aches) 03/2015 - 07/2013
2	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2021 - 01/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 08/2012
2	Peptic Ulcer (Peptic Ulcers) 08/2011 - 12/2004
2	Gastritis 08/2011 - 12/2004
2	Chronic Hepatitis C 09/2007 - 04/2004
2	Lactose Intolerance (Intolerance, Lactose) 01/2006 - 04/2003
2	Diarrhea 05/2004 - 01/2003
1	Atrophic Gastritis 01/2022
1	Achlorhydria (Hypochlorhydria) 01/2022
1	Morbid Obesity 01/2021
1	Constipation 01/2021
1	Gastroesophageal Reflux (GERD) 01/2021
1	Dyspepsia (Indigestion) 01/2021
1	Venous Thromboembolism 07/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Colonic Polyps 01/2020
1	Carcinoma (Carcinomatosis) 12/2019
1	Gitelman Syndrome 01/2019
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 08/2018
1	Hidradenitis Suppurativa 12/2016
1	Obesity 01/2015
1	Type I Syndactyly 09/2014
1	Colonic Diverticulitis 08/2014
1	Fever (Fevers) 08/2014
1	Ulcer 07/2013

Drug/Important Bio-Agent (IBA)

23	Mesalamine (Mesalazine)FDA LinkGeneric 01/2020 - 01/2004
14	Adalimumab (Humira)FDA Link 05/2022 - 09/2008
14	Infliximab (Remicade)FDA Link 02/2022 - 02/2011
11	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2004
10	Leukocyte L1 Antigen Complex (Calgranulin)IBA 06/2022 - 01/2009
10	Rifaximin (L 105)FDA Link 01/2020 - 04/2003
7	AntibodiesIBA 12/2021 - 03/2003
5	golimumab FDA Link 12/2021 - 11/2016
5	C-Reactive ProteinIBA 01/2021 - 08/2014
5	Proton Pump InhibitorsIBA 01/2021 - 08/2011
5	Pharmaceutical PreparationsIBA 10/2016 - 04/2003
4	Biosimilar PharmaceuticalsIBA 05/2022 - 12/2017
4	SteroidsIBA 01/2021 - 06/2006
4	Budesonide (Pulmicort)FDA LinkGeneric 12/2019 - 06/2006
4	balsalazide (Colazal)FDA LinkGeneric 12/2009 - 11/2004
3	CT-P13IBA 02/2022 - 12/2017
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2012
3	Clarithromycin (Biaxin)FDA LinkGeneric 06/2012 - 07/2002
3	Amoxicillin (Wymox)FDA LinkGeneric 08/2011 - 07/2002
3	Lactose FDA LinkGeneric 03/2006 - 04/2003
2	Ustekinumab (CNTO 1275)FDA Link 08/2021 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 09/2008
2	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 01/2020 - 09/2008
2	Syndecan-1 (Syndecan 1)IBA 09/2014 - 09/2014
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2014 - 09/2014
2	Tinidazole FDA Link 08/2011 - 12/2004
2	ProdrugsIBA 12/2009 - 09/2008
2	Beclomethasone (Beclometasone)FDA Link 06/2006 - 08/2005
2	Lactulose (Duphalac)FDA LinkGeneric 03/2006 - 04/2003
2	ranitidine bismuth citrate (Tritec)FDA Link 12/2004 - 07/2002
2	RNA (Ribonucleic Acid)IBA 04/2004 - 07/2002
2	TransglutaminasesIBA 11/2003 - 03/2003
2	Glutens (Glutelin)IBA 01/2003 - 07/2002
1	GP2017IBA 05/2022
1	Biological ProductsIBA 04/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	CarcinogensIBA 01/2022
1	AcetaldehydeIBA 01/2022
1	Cysteine (L-Cysteine)FDA Link 01/2022
1	risankizumabIBA 11/2021
1	Omalizumab (Xolair)FDA Link 10/2021
1	pembrolizumabIBA 05/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	gingerolIBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2020
1	SmokeIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	vedolizumabIBA 08/2019
1	Interleukin-10 (Interleukin 10)IBA 12/2018
1	Vitamin D FDA LinkGeneric 12/2016
1	prucaloprideIBA 04/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2015
1	AcidsIBA 05/2014
1	Capsules (Microcapsules)IBA 08/2013
1	Bevacizumab (Avastin)FDA Link 08/2012

Therapy/Procedure

24	Therapeutics 12/2021 - 07/2002
7	Gluten-Free Diet 01/2015 - 04/2003
4	Aftercare (After-Treatment) 08/2012 - 09/2007
1	Appendectomy 01/2020
1	Conservative Treatment 11/2013